[PRESS RELEASES] – TALLAHASSEE, Fla., April 29, 2026 – Trulieve Cannabis Corp., a leading and top-performing cannabis company in the U.S., announced that it has filed applications with the U.S. Drug Enforcement Administration (DEA) to register certain state‑licensed medical marijuana operations pursuant to the expedited registration pathway established by the recent rescheduling of medical marijuana to Schedule III under the Controlled Substances Act.
"DEA registration for our medical business marks a historic step forward for Trulieve and the patients we serve," Trulieve CEO Kim Rivers said. "With over 200 dispensaries serving only medical patients, Trulieve is uniquely positioned to set the bar as a responsible operator in U.S. cannabis."
Following the reclassification of medical marijuana to Schedule III, the DEA established an expedited registration process for eligible state‑licensed medical marijuana operators. For operators that apply within 60 days, licensure to manufacture, distribute, and dispense Schedule III medical marijuana products is deemed approved unless otherwise notified.
